These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32348489)

  • 41. Covid-19 Vaccine Trials and Incarcerated People - The Ethics of Inclusion.
    Strassle C; Jardas E; Ochoa J; Berkman BE; Danis M; Rid A; Taylor HA
    N Engl J Med; 2020 Nov; 383(20):1897-1899. PubMed ID: 33085884
    [No Abstract]   [Full Text] [Related]  

  • 42. Covid-19: The Pandemic of Our Time.
    Murphy JFA
    Ir Med J; 2020 Apr; 113(4):46. PubMed ID: 32267942
    [No Abstract]   [Full Text] [Related]  

  • 43. Vaccine designers take first shots at COVID-19.
    Cohen J
    Science; 2020 Apr; 368(6486):14-16. PubMed ID: 32241928
    [No Abstract]   [Full Text] [Related]  

  • 44. After A COVID-19 Vaccine: Collaboration Or Competition?
    Meyer H
    Health Aff (Millwood); 2020 Nov; 39(11):1856-1860. PubMed ID: 32986500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. COVID-19 and mRNA Vaccines-First Large Test for a New Approach.
    Abbasi J
    JAMA; 2020 Sep; 324(12):1125-1127. PubMed ID: 32880613
    [No Abstract]   [Full Text] [Related]  

  • 46. Status of COVID-19 vaccine development.
    Taxt AM; Grødeland G; Lind A; Müller F
    Tidsskr Nor Laegeforen; 2020 Sep; 140(13):. PubMed ID: 32998488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Building Trust to Achieve Confidence in COVID-19 Vaccines.
    Opel DJ; Salmon DA; Marcuse EK
    JAMA Netw Open; 2020 Oct; 3(10):e2025672. PubMed ID: 33079194
    [No Abstract]   [Full Text] [Related]  

  • 48. Rational Vaccine Design in the Time of COVID-19.
    Burton DR; Walker LM
    Cell Host Microbe; 2020 May; 27(5):695-698. PubMed ID: 32407707
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2?
    McPartlin SO; Morrison J; Rohrig A; Weijer C
    BMJ; 2020 Nov; 371():m4258. PubMed ID: 33168564
    [No Abstract]   [Full Text] [Related]  

  • 50. Low genetic diversity may be an Achilles heel of SARS-CoV-2.
    Rausch JW; Capoferri AA; Katusiime MG; Patro SC; Kearney MF
    Proc Natl Acad Sci U S A; 2020 Oct; 117(40):24614-24616. PubMed ID: 32958678
    [No Abstract]   [Full Text] [Related]  

  • 51. Keeping track of the SARS-CoV-2 vaccine pipeline.
    Parker EPK; Shrotri M; Kampmann B
    Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
    [TBL] [Abstract][Full Text] [Related]  

  • 52. COVID-19 vaccines for all?
    Usher AD
    Lancet; 2020 Jun; 395(10240):1822-1823. PubMed ID: 32534638
    [No Abstract]   [Full Text] [Related]  

  • 53. COVID-19 vaccination clinical trials should consider multiple doses of BCG.
    Ayoub BM
    Pharmazie; 2020 Apr; 75(4):159. PubMed ID: 32295694
    [No Abstract]   [Full Text] [Related]  

  • 54. Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities.
    Wang EA; Zenilman J; Brinkley-Rubinstein L
    JAMA; 2020 Sep; 324(11):1031-1032. PubMed ID: 32808972
    [No Abstract]   [Full Text] [Related]  

  • 55. Next-generation vaccine platforms for COVID-19.
    van Riel D; de Wit E
    Nat Mater; 2020 Aug; 19(8):810-812. PubMed ID: 32704139
    [No Abstract]   [Full Text] [Related]  

  • 56. From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development.
    Ma C; Su S; Wang J; Wei L; Du L; Jiang S
    Microbes Infect; 2020; 22(6-7):245-253. PubMed ID: 32437926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. COVID-19 vaccines and neglected pregnancy.
    Dashraath P; Nielsen-Saines K; Madhi SA; Baud D
    Lancet; 2020 Sep; 396(10252):e22. PubMed ID: 32861313
    [No Abstract]   [Full Text] [Related]  

  • 58. Talk to Patients About: Why Will It Take So Long for a COVID-19 Vaccine?
    Price S
    Tex Med; 2020 Jun; 116(6):19. PubMed ID: 32645183
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapid and robust bioanalytical assays are critical for SARS-CoV-2 therapeutic and vaccine development and beyond.
    Kar S; Islam R
    Bioanalysis; 2020 Sep; 12(17):1199-1203. PubMed ID: 32453605
    [No Abstract]   [Full Text] [Related]  

  • 60. Coronavirus Vaccine: Light at the End of the Tunnel.
    Ella KM; Mohan VK
    Indian Pediatr; 2020 May; 57(5):407-410. PubMed ID: 32291382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.